FORUM Pharmaceuticals, Inc.

Deborah Dunsire has been appointed president and CEO of H. Lundbeck AS , as of Sept. 1, 2018. Anders Götzsche , who has been acting as interim CEO and CFO since November 2017, will resume his po

Privately-held XTuit Pharmaceuticals Inc. has tapped experienced oncology leader Deborah Dunsire as president and CEO as the company’s lead drugs mature towards the clinic. The Waltham, Massachuse

Minerva's stock (NASDAQ) rocketed following the release of topline Phase IIb data for schizophrenia drug MIN-101 – leaping up from its closing price of $3.55 per share on May 25 to a peak of $13.16 pe

As the venture capital arm of FMR LLC, the parent company of $2 trillion Fidelity Investments, F-Prime Capital Partners can afford to invest large amounts with a long-term perspective and to extend it